Literature DB >> 28587736

A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation.

Takuya Takeichi1, Katsuhiko Tsukamoto2, Yusuke Okuno3, Daiei Kojima4, Michihiro Kono5, Yasushi Suga6, Masashi Akiyama7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28587736     DOI： 10.1016/j.jdermsci.2017.05.012

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  1 in total

1.  Feasibility Study for the Long-Term Management of Refractory Hyperkeratotic Eczema with Calcipotriol and Betamethasone Dipropionate (Daivobet®), Viaminate and Concomitant Conventional Therapies: A Retrospective Study.

Authors:  Amelia Nabatanzi; Magesa Mafuru; Musa Male; Chunxia Tian; Lingyun Zhang; Ting Wu; Shidi Wu; Changzheng Huang
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-10-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.